Pediatric surgical oncology: Management of rhabdomyosarcoma

Surgical Oncology

Volumn 16, Issue 3, 2007, Pages 173-185

  Leaphart, Cynthia ^a   Rodeberg, David ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Rhabdomyosarcoma prognosis; RMS; Surgical guidelines

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; MELPHALAN; VINCRISTINE;

ABDOMINAL WALL; AGE DISTRIBUTION; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HEPATOBILIARY SYSTEM; HISTOLOGY; HUMAN; LIVER TOXICITY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METASTASIS; MUSCLE BIOPSY; NEUROTOXICITY; PERIANAL ABSCESS; PERINEUM; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHABDOMYOSARCOMA; RISK ASSESSMENT; SURGICAL TECHNIQUE; THORAX WALL; UROGENITAL SYSTEM;

CHILD; CHILD, PRESCHOOL; HUMANS; MEDICAL ONCOLOGY; NEOPLASM STAGING; PROGNOSIS; RHABDOMYOSARCOMA;

EID: 36048986046     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.07.003     Document Type: Review

References (107)

1. Pack G.T., and Eberhart W.F. Rhabdomyosarcoma of skeletal muscle; report of 100 cases. Surgery 32 (1952) 1023-1064
2. Meza J.L., Anderson J., Pappo A.S., and Meyer W.H. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Journal of Clinical Oncology 24 (2006) 3844-3851
3. Pappo A.S., Shapiro D.N., Crist W.M., and Maurer H.M. Biology and therapy of pediatric rhabdomyosarcoma. Journal of Clinical Oncology 13 (1995) 2123-2139
4. Crist W.M., Anderson J.R., Meza J.L., et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. Journal of Clinical Oncology 19 (2001) 3091-3102
5. In: Ries LAG M.D., Krapcho M., Mariotto A., Miller B.A., Feuer E.J., Clegg L., et al. (Eds). SEER cancer statistics review (1975-2004)
6. Miller R.W., and Young Jr. J.L. Novakovic B: childhood cancer. Cancer 75 (1995) 395-405
7. Toro J.R., Travis L.B., Wu H.J., et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. International Journal of Cancer 119 (2006) 2922-2930
8. Newton Jr. W.A., Gehan E.A., Webber B.L., et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 76 (1995) 1073-1085
9. Merlino G., and Helman L.J. Rhabdomyosarcoma-working out the pathways. Oncogene 18 (1999) 5340-5348
10. Taulli R., Scuoppo C., Bersani F., et al. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Research 66 (2006) 4742-4749
11. Chen Y., Takita J., Mizuguchi M., et al. Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET over expression. Genes Chromosomes & Cancer 46 (2007) 348-358
12. Scrable H., Cavenee W., Ghavimi F., et al. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 7480-7484
13. Scrable H.J., Johnson D.K., Rinchik E.M., and Cavenee W.K. Rhabdomyosarcoma-associated locus and MYOD1 are syntenic but separate loci on the short arm of human chromosome 11. Proceedings of the National Academy of Sciences of the United States of America 87 (1990) 2182-2186
14. Scrable H.J., Witte D.P., Lampkin B.C., and Cavenee W.K. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329 (1987) 645-647
15. El-Badry O.M., Minniti C., Kohn E.C., et al. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth & Differentiation 1 (1990) 325-331
16. Borycki A.G., Li J., Jin F., et al. PAX3 functions in cell survival and in PAX7 regulation. Development 126 (1999) 1665-1674
17. Peng H., and Huard J. Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transplant Immunology 12 (2004) 311-319
18. Parham D.M., Qualman S.J., Teot L., et al. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. American Journal of Surgical Pathology 31 (2007) 895-901
19. Li F.P., and Fraumeni Jr. J.F. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Annals of Internal Medicine 71 (1969) 747-752
20. Malkin D., and Friend S.H. Correction: a Li-Fraumeni syndrome p53 mutation. Science 259 (1993) 878
21. Malkin D., Li F.P., Strong L.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 (1990) 1233-1238
22. Varley J.M., McGown G., Thorncroft M., et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Research 57 (1997) 3245-3252
23. Ferrari A., Bisogno G., Macaluso A., et al. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Cancer 109 (2007) 1406-1412
24. Wu R., Lopez-Correa C., Rutkowski J.L., et al. Germline mutations in NF1 patients with malignancies. Genes Chromosomes & Cancer 26 (1999) 376-380
25. Lampe A.K., Seymour G., Thompson P.W., et al. Familial neurofibromatosis microdeletion syndrome complicated by rhabdomyosarcoma. Archives of Disease in Childhood 87 (2002) 444-445
26. Gorlin R.J. Nevoid basal cell carcinoma (Gorlin) syndrome. Genetics in Medicine 6 (2004) 530-539
27. Hahn H., Wojnowski L., Specht K., et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. Journal of Biological Chemistry 275 (2000) 28341-28344
28. Pazzaglia S. Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis. Cancer Letters 234 (2006) 124-134
29. Calzada-Wack J., Schnitzbauer U., Walch A., et al. Analysis of the PTCH coding region in human rhabdomyosarcoma. Human Mutation 20 (2002) 233-234
30. Tostar U., Malm C.J., Meis-Kindblom J.M., et al. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. Journal of Pathology 208 (2006) 17-25
31. Ruymann F.B., Maddux H.R., Ragab A., et al. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center). Medical and Pediatric Oncology 16 (1988) 33-39
32. Toth B., Patil K., Erickson J., and Gannett P. Carcinogenesis by benzenediazonium sulfate in mice. In Vivo 12 (1998) 379-382
33. Grufferman S., Schwartz A.G., Ruymann F.B., and Maurer H.M. Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes & Control 4 (1993) 217-224
34. Grufferman S., Wang H.H., DeLong E.R., et al. Environmental factors in the etiology of rhabdomyosarcoma in childhood. Journal of the National Cancer Institute 68 (1982) 107-113
35. Pedrick T.J., Donaldson S.S., and Cox R.S. Rhabdomyosarcoma: the Stanford experience using a TNM staging system. Journal of Clinical Oncology 4 (1986) 370-378
36. Willman J.H., White K., and Coffin C.M. Pediatric core needle biopsy: strengths and limitations in evaluation of masses. Pediatric and Developmental Pathology 4 (2001) 46-52
37. Salomao D.R., Sigman J.D., Greenebaum E., and Cohen M.B. Rhabdomyosarcoma presenting as a parotid gland mass in pediatric patients: fine-needle aspiration biopsy findings. Cancer 84 (1998) 245-251
38. Kilpatrick S.E., Bergman S., Pettenati M.J., and Gulley M.L. The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas. Modern Pathology 19 (2006) 815-819
39. Hays D.M., Lawrence Jr. W., Wharam M., et al. Primary reexcision for patients with 'microscopic residual' tumor following initial excision of sarcomas of trunk and extremity sites. Journal of Pediatric Surgery 24 (1989) 5-10
40. Hays D.M., Lawrence Jr. W., Crist W.M., et al. Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the Intergroup Rhabdomyosarcoma Study. Journal of Pediatric Surgery 25 (1990) 719-723
41. Crist W.M., Garnsey L., Beltangady M.S., et al. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. Journal of Clinical Oncology 8 (1990) 443-452
42. Mandell L., Ghavimi F., LaQuaglia M., and Exelby P. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma. Medical and Pediatric Oncology 18 (1990) 466-471
43. Wiener E.S., Anderson J.R., Ojimba J.I., et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?. Seminars in Pediatric Surgery 10 (2001) 146-152
44. Neville H.L., Andrassy R.J., Lobe T.E., et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). Journal of Pediatric Surgery 35 (2000) 317-321
45. McMulkin H.M., Yanchar N.L., Fernandez C.V., and Giacomantonio C. Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatric Surgery International 19 (2003) 453-456
46. Neville H.L., Andrassy R.J., Lally K.P., et al. Lymphatic mapping with sentinel node biopsy in pediatric patients. Journal of Pediatric Surgery 35 (2000) 961-964
47. Pappo A.S., Shapiro D.N., and Crist W.M. Rhabdomyosarcoma. Biology and treatment. Pediatric Clinics of North America 44 (1997) 953-972
48. Wiener E.S. Pediatric surgical oncology. Current Opinion in Pediatrics 5 (1993) 110-116
49. Hayes-Jordan A., Doherty D.K., West S.D., et al. Outcome after surgical resection of recurrent rhabdomyosarcoma. Journal of Pediatric Surgery 41 (2006) 633-638 [discussion 633-638]
50. Spunt S.L., Smith L.M., Ruymann F.B., et al. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the Children's Oncology Group. Clinical Cancer Research 10 (2004) 6072-6079
51. Baker K.S., Anderson J.R., Link M.P., et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Journal of Clinical Oncology 18 (2000) 2427-2434
52. Breitfeld P.P., Lyden E., Raney R.B., et al. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group. Journal of Pediatric Hematology Oncology 23 (2001) 225-233
53. Sandler E., Lyden E., Ruymann F., et al. Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Medical and Pediatric Oncology 37 (2001) 442-448
54. Pappo A.S., Lyden E., Breitfeld P., et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. Journal of Clinical Oncology 25 (2007) 362-369
55. Tefft M., Lindberg R.D., and Gehan E.A. Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study. National Cancer Institute Monographs (1981) 75-81
56. Wharam M.D., Hanfelt J.J., Tefft M.C., et al. Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. International Journal of Radiation Oncology Biology Physics 38 (1997) 797-804
57. Mandell L., Ghavimi F., Peretz T., et al. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4000 cGy. Journal of Clinical Oncology 8 (1990) 1536-1542
58. Raney Jr. R., Hays D.M., Tefft M., and Triche T.J. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo P., and Poplack D.G. (Eds). Principles and practice of pediatric oncology (1993), JB Lippincott Co, Philadelphia 769-794
59. Donaldson S.S., Meza J., Breneman J.C., et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. International Journal of Radiation Oncology Biology Physics 51 (2001) 718-728
60. Puri D.R., Wexler L.H., Meyers P.A., et al. The challenging role of radiation therapy for very young children with rhabdomyosarcoma. International Journal of Radiation Oncology Biology Physics 65 (2006) 1177-1184
61. Karcioglu Z.A., Hadjistilianou D., Rozans M., and DeFrancesco S. Orbital rhabdomyosarcoma. Cancer Causes and Control 11 (2004) 328-333
62. Pappo A.S., Meza J.L., Donaldson S.S., et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. Journal of Clinical Oncology 21 (2003) 638-645
63. Wiener E.S. Head and neck rhabdomyosarcoma. Seminars in Pediatric Surgery 3 (1994) 203-206
64. Walterhouse D.O., Pappo A.S., Baker K.S., et al. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group. Cancer 92 (2001) 3135-3146
65. Raney R.B., Meza J., Anderson J.R., et al. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. Medical and Pediatric Oncology 38 (2002) 22-32
66. Michalski J.M., Meza J., Breneman J.C., et al. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. International Journal of Radiation Oncology Biology Physics 59 (2004) 1027-1038
67. Hawkins D.S., Anderson J.R., Paidas C.N., et al. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study. Journal of Clinical Oncology 19 (2001) 3073-3079
68. Blatt J., Snyderman C., Wollman M.R., et al. Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood. Medical and Pediatric Oncology 28 (1997) 294-298
69. Andrassy R.J., Wiener E.S., Raney R.B., et al. Thoracic sarcomas in children. Annals of Surgery 227 (1998) 170-173
70. Soyer T., Karnak I., Ciftci A.O., et al. The results of surgical treatment of chest wall tumors in childhood. Pediatric Surgery International 22 (2006) 135-139
71. Crist W.M., Raney Jr. R.B., Newton W., et al. Intrathoracic soft tissue sarcomas in children. Cancer 50 (1982) 598-604
72. Raney Jr. R.B. Localized sarcoma of the chest wall. Medical and Pediatric Oncology 12 (1984) 116-118
73. Raney Jr. R.B., Ragab A.H., Ruymann F.B., et al. Soft-tissue sarcoma of the trunk in childhood. Results of the intergroup rhabdomyosarcoma study. Cancer 49 (1982) 2612-2616
74. Young M.M., Kinsella T.J., Miser J.S., et al. Treatment of sarcomas of the chest wall using intensive combined modality therapy. International Journal of Radiation Oncology Biology Physics 16 (1989) 49-57
75. Chui C.H., Billups C.A., Pappo A.S., et al. Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk-the St Jude Children's Research Hospital experience. Journal of Pediatric Surgery 40 (2005) 1691-1695
76. Ortega J.A., Wharam M., Gehan E.A., et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology 9 (1991) 796-801
77. Beech T.R., Moss R.L., Anderson J.A., et al. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group. Journal of Pediatric Surgery 34 (1999) 668-671
78. Ito F., Watanabe Y., Harada T., et al. Combined resection of abdominal aorta and inferior vena cava for retroperitoneal rhabdomyosarcoma invading the aortoiliac bifurcation. Journal of Pediatric Surgery 33 (1998) 1566-1568
79. Blakely M.L., Lobe T.E., Anderson J.R., et al. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?. Journal of Pediatric Surgery 34 (1999) 736-741 [discussion 741-732]
80. Raney R.B., Stoner J.A., Walterhouse D.O., et al. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997. Pediatric Blood Cancer 42 (2004) 618-625
81. Spunt S.L., Lobe T.E., Pappo A.S., et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. Journal of Pediatric Surgery 35 (2000) 309-316
82. Akers D.R., and Needham M.E. Sarcoma botryoides (rhabdomyosarcoma) of the bile ducts with survival. Journal of Pediatric Surgery 6 (1971) 474-479
83. Davis G.L., Kissane J.M., and Ishak K.G. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the biliary tree. Report of five cases and a review of the literature. Cancer 24 (1969) 333-342
84. Blakely M.L., Andrassy R.J., Raney R.B., et al. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. Journal of Pediatric Surgery 38 (2003) 347-353
85. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology 13 (1995) 610-630
86. Maurer H.M., Gehan E.A., Beltangady M., et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 71 (1993) 1904-1922
87. Castellino S.M., and McLean T.W. Pediatric genitourinary tumors. Current Opinion in Oncology 19 (2007) 248-253
88. Ferrer F.A., Isakoff M., and Koyle M.A. Bladder/prostate rhabdomyosarcoma: past, present and future. Journal of Urology 176 (2006) 1283-1291
89. Silvan A.M., Gordillo M.J., Lopez A.M., et al. Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in children. Medical and Pediatric Oncology 29 (1997) 573-575
90. Merguerian P.A., Agarwal S., Greenberg M., et al. Outcome analysis of rhabdomyosarcoma of the lower urinary tract. Journal of Urology 160 (1998) 1191-1194 [discussion 1216]
91. Arndt C., Rodeberg D., Breitfeld P.P., et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. Journal of Urology 171 (2004) 2396-2403
92. Yeung C.K., Ward H.C., Ransley P.G., et al. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. British Journal of Cancer 70 (1994) 1000-1003
93. Hays D.M., Shimada H., Raney Jr. R.B., et al. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents. Cancer 61 (1988) 1893-1903
94. Hays D.M., Shimada H., Raney Jr. R.B., et al. Sarcomas of the vagina and uterus: the Intergroup Rhabdomyosarcoma Study. Journal of Pediatric Surgery 20 (1985) 718-724
95. Raney Jr. R.B., Gehan E.A., Hays D.M., et al. Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II. Cancer 66 (1990) 2072-2081
96. Arndt C.A., Donaldson S.S., Anderson J.R., et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. Cancer 91 (2001) 2454-2468
97. Sugita Y., Clarnette T.D., Cooke-Yarborough C., et al. Testicular and paratesticular tumours in children: 30 years' experience. Australian and New Zealand Journal of Surgery 69 (1999) 505-508
98. Ferrari A., Bisogno G., Casanova M., et al. Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? The experience of Italian and German Soft Tissue Sarcoma Cooperative Group. Pediatric Blood Cancer 42 (2004) 134-138
99. Ferrari A., Casanova M., Massimino M., et al. The management of paratesticular rhabdomyosarcoma: a single institutional experience with 44 consecutive children. Journal of Urology 159 (1998) 1031-1034
100. Rodeberg D., and Paidas C. Childhood rhabdomyosarcoma. Seminars in Pediatric Surgery 15 (2006) 57-62
101. Raney Jr. R.B., Tefft M., Lawrence Jr. W., et al. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983. Cancer 60 (1987) 2337-2343
102. Wiener E.S., Lawrence W., Hays D., et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. Journal of Pediatric Surgery 29 (1994) 171-177 [discussion 178]
103. Hermans B.P., Foster R.S., Bihrle R., et al. Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?. Journal of Urology 160 (1998) 2074-2077
104. Raney R.B., Anderson J.R., Barr F.G., et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. Journal of Pediatric Hematology Oncology 23 (2001) 215-220
105. Smith L.M., Anderson J.R., Qualman S.J., et al. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. Journal of Clinical Oncology 19 (2001) 4058-4064
106. Wharam M.D., Meza J., Anderson J., et al. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology 22 (2004) 1902-1908
107. Breneman J.C., Lyden E., Pappo A.S., et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV. Journal of Clinical Oncology 21 (2003) 78-84